If you're considering GLP-1 medication for weight loss in Hong Kong, understanding the side effects is essential. The good news: most side effects are predictable, manageable, and temporary. The key is knowing what to expect and when to seek medical advice.

→ For a complete overview, see our Complete Guide to GLP-1 Weight Loss in Hong Kong.
GLP-1 receptor agonists work by mimicking the natural GLP-1 hormone, which acts on receptors throughout the body — not just in the pancreas but also in the brain, stomach, and gut (Drucker DJ. Cell Metab. 2018;27(4):740-756. PMID: 29617641).
The most common side effects are gastrointestinal, directly related to the mechanism that makes these drugs effective: slowing gastric emptying and altering appetite signalling. In other words, the side effects and the benefits come from the same biological pathways.
Prevalence: 40–50% of patients during dose escalation(Based on clinical guidelines and prescribing information)
Nausea is the most frequently reported side effect across all GLP-1 medications. It is typically:
Management strategies:
Prevalence: 15–30% of patients(Based on clinical guidelines and prescribing information)
Changes in bowel habits are common as GLP-1 medications alter gut motility. Diarrhoea is usually mild and resolves within the first few weeks.
Management:
Prevalence: 10–25% of patients(Based on clinical guidelines and prescribing information)
Paradoxically, some patients experience constipation rather than diarrhoea, due to slowed gut motility.
Management:
Prevalence: 5–15% of patients(Based on clinical guidelines and prescribing information)
Usually occurs during dose escalation and resolves as your body adjusts.
Management:
Prevalence: 20–30% of patients(Based on clinical guidelines and prescribing information)
This is both a side effect and the primary mechanism of action. While reduced appetite drives weight loss, some patients find it challenging to eat enough to meet nutritional needs.
Management:
Mild redness, swelling, or itching at the injection site occurs in a small percentage of patients. Rotate injection sites (abdomen, thigh, upper arm) to minimise this.
Some patients report headaches, particularly in the early weeks. These are usually mild and may be related to changes in eating patterns or blood sugar levels. Stay hydrated and maintain regular meal timing.
Fatigue may occur as your body adjusts to lower caloric intake. Ensure adequate nutrition, sleep, and hydration. Fatigue that persists beyond the first few weeks should be discussed with your doctor.
Particularly relevant for patients with diabetes who are also on other blood-sugar-lowering medications. Hypoglycaemia (low blood sugar) can cause dizziness. If you're on insulin or sulfonylureas, your doctor may need to adjust those doses.
Risk: <1% of patients(Based on clinical guidelines and prescribing information)
Inflammation of the pancreas is a rare but serious potential side effect.
Symptoms to watch for:
Action: Stop the medication and seek immediate medical attention if you experience these symptoms.
Risk: Slightly elevated compared to placebo(Based on clinical guidelines and prescribing information)
Rapid weight loss from any cause can increase the risk of gallstones. GLP-1 medications may also directly affect gallbladder motility.
Symptoms:
GLP-1 receptor agonists carry a boxed warning regarding thyroid C-cell tumours based on animal studies. This risk has not been confirmed in humans, but the medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)(Based on clinical guidelines and prescribing information).
| Side Effect | Ozempic | Rybelsus | Mounjaro |
|---|---|---|---|
| Nausea | ●●●○ | ●●○○ | ●●●○ |
| Diarrhoea | ●●○○ | ●●○○ | ●●●○ |
| Constipation | ●●○○ | ●○○○ | ●●○○ |
| Vomiting | ●●○○ | ●○○○ | ●●○○ |
| Appetite suppression | ●●●○ | ●●○○ | ●●●● |
Scale: ● = mild/infrequent, ●●●● = strong/frequent. Based on clinical trial data; individual experiences vary.
Contact your noah™ doctor if you experience:
Seek emergency care if you experience:
For the vast majority of patients, yes. Nausea typically peaks during dose escalation and subsides within a few weeks at each dose level. If it persists, your doctor can adjust your treatment plan.
Your doctor may recommend anti-nausea medication (e.g., ondansetron) for short-term relief during dose escalation(Based on clinical guidelines and prescribing information). Do not self-medicate without consulting your doctor.
GI side effects with Mounjaro at higher doses can be somewhat more pronounced, consistent with its greater weight-loss efficacy. However, tolerability varies widely between individuals(Based on clinical guidelines and prescribing information).
Not necessarily — but the mechanisms that cause GI side effects (slowed gastric emptying, appetite reduction) are part of how GLP-1 medications promote weight loss. Some side effects indicate the drug is active, but absence of side effects does not mean the medication is ineffective.
Some patients report increased hair shedding (telogen effluvium) during rapid weight loss. This is generally related to the weight loss itself rather than the medication specifically, and is usually temporary(Based on clinical guidelines and prescribing information).
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any medication. Treatment suitability is determined by your prescribing doctor based on your individual health profile.
© 2026 noah™. All rights reserved.
This article is for general information only and isn’t medical advice. Talk to a doctor before starting any treatment.
That’s what a consult is for. A few minutes of questions, then a registered doctor by text or video.